Skip to main content

Advertisement

SpringerLink
Log in

Symptomatic late-onset sialadenitis after radioiodine therapy in thyroid cancer

  • Original Article
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

Abstract

Objective

The aim of this study was to document the subjective and objective findings of symptomatic late-onset sialadenitis after radioiodine therapy in patients with differentiated thyroid cancer.

Methods

Subjective symptoms related to sialadenitis and Tc-99m pertechnetate salivary gland scintigram findings were assessed in 118 patients (26 males, 92 females) both before and during the late phase (mean 338 days) after the administration of radioiodine.

Results

Twelve of the 118 patients (10.2 %) complained of symptomatic sialadenitis in the late phase without symptoms during the early phase (within 7 days of radioiodine administration). Significant associations were found between subjective symptoms and visual scintigram findings during the late phase (p = 0.023). Furthermore, uptake and excretion by both parotid glands were significantly affected by radioiodine therapy.

Conclusions

Symptomatic late-onset sialadenitis occurred at an incidence of 10.2 %, and salivary gland function was affected in both parotids in most patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Jhiang SM, Cho JY, Ryu KY, DeYoung BR, Smanik PA, McGaughy VR, et al. An immunohistochemical study of Na+/I− symporter in human thyroid tissues and salivary gland tissues. Endocrinology. 1998;139:4416–9.

    Article  PubMed  CAS  Google Scholar 

  2. Cavalieri RR. Iodine metabolism and thyroid physiology: current concepts. Thyroid. 1997;7:177–81.

    Article  PubMed  CAS  Google Scholar 

  3. Raza H, Khan AU, Hameed A, Khan A. Quantitative evaluation of salivary gland dysfunction after radioiodine therapy using salivary gland scintigraphy. Nucl Med Commun. 2006;27:495–9.

    Article  PubMed  CAS  Google Scholar 

  4. Allweiss P, Braunstein GD, Katz A, Waxman A. Sialadenitis following I-131 therapy for thyroid carcinoma: concise communication. J Nucl Med. 1984;25:755–8.

    PubMed  CAS  Google Scholar 

  5. DiRusso G, Kern KA. Comparative analysis of complications from I-131 radioablation for well-differentiated thyroid cancer. Surgery. 1994;116:1024–30.

    PubMed  CAS  Google Scholar 

  6. Malpani BL, Samuel AM, Ray S. Quantification of salivary gland function in thyroid cancer patients treated with radioiodine. Int J Radiat Oncol Biol Phys. 1996;35:535–40.

    Article  PubMed  CAS  Google Scholar 

  7. Alexander C, Bader JB, Schaefer A, Finke C, Kirsch CM. Intermediate and long-term side effects of high-dose radioiodine therapy for thyroid carcinoma. J Nucl Med. 1998;39:1551–4.

    PubMed  CAS  Google Scholar 

  8. Bohuslavizki KH, Brenner W, Lassmann S, Tinnemeyer S, Tonshoff G, Sippel C, et al. Quantitative salivary gland scintigraphy in the diagnosis of parenchymal damage after treatment with radioiodine. Nucl Med Commun. 1996;17:681–6.

    Article  PubMed  CAS  Google Scholar 

  9. Almeida JP, Sanabria AE, Lima EN, Kowalski LP. Late side effects of radioactive iodine on salivary gland function in patients with thyroid cancer. Head Neck. 2011;33:686–90.

    Article  PubMed  Google Scholar 

  10. Helman J, Turner RJ, Fox PC, Baum BJ. 99mTc-pertechnetate uptake in parotid acinar cells by the Na+/K+/Cl− co-transport system. J Clin Invest. 1987;79:1310–3.

    Article  PubMed  CAS  Google Scholar 

  11. Newkirk KA, Ringel MD, Wartofsky L, Burman KD. The role of radioactive iodine in salivary gland dysfunction. Ear Nose Throat J. 2000;79:460–8.

    PubMed  CAS  Google Scholar 

  12. Solans R, Bosch JA, Galofre P, Porta F, Rosello J, Selva-O’Callagan A, et al. Salivary and lacrimal gland dysfunction (sicca syndrome) after radioiodine therapy. J Nucl Med. 2001;42:738–43.

    PubMed  CAS  Google Scholar 

  13. Mandel SJ, Mandel L. Radioactive iodine and the salivary glands. Thyroid. 2003;13:265–71.

    Article  PubMed  CAS  Google Scholar 

  14. Bohuslavizki KH, Brenner W, Lassmann S, Tinnemeyer S, Kalina S, Clausen M, et al. Quantitative salivary gland scintigraphy—a recommended examination prior to and after radioiodine therapy. Nuklearmedizin. 1997;36:103–9.

    PubMed  CAS  Google Scholar 

  15. Levenson D, Gulec S, Sonenberg M, Lai E, Goldsmith SJ, Larson SM. Peripheral facial nerve palsy after high-dose radioiodine therapy in patients with papillary thyroid carcinoma. Ann Intern Med. 1994;120:576–8.

    Article  PubMed  CAS  Google Scholar 

  16. Klutmann S, Bohuslavizki KH, Kroger S, Bleckmann C, Brenner W, Mester J, et al. Quantitative salivary gland scintigraphy. J Nucl Med Technol. 1999;27:20–6.

    PubMed  CAS  Google Scholar 

  17. Malpani BL, Samuel AM, Ray S. Differential kinetics of parotid and submandibular gland function as demonstrated by scintigraphic means and its possible implications. Nucl Med Commun. 1995;16:706–9.

    Article  PubMed  CAS  Google Scholar 

  18. Hazuka MB, Martel MK, Marsh L, Lichter AS, Wolf GT. Preservation of parotid function after external beam irradiation in head and neck cancer patients: a feasibility study using 3-dimensional treatment planning. Int J Radiat Oncol Biol Phys. 1993;27:731–7.

    Article  PubMed  CAS  Google Scholar 

  19. Stephens LC, Schultheiss TE, Price RE, Ang KK, Peters LJ. Radiation apoptosis of serous acinar cells of salivary and lacrimal glands. Cancer. 1991;67:1539–43.

    Article  PubMed  CAS  Google Scholar 

  20. Jentzen W, Schneider E, Freudenberg L, Eising EG, Gorges R, Muller SP, et al. Relationship between cumulative radiation dose and salivary gland uptake associated with radioiodine therapy of thyroid cancer. Nucl Med Commun. 2006;27:669–76.

    Article  PubMed  CAS  Google Scholar 

  21. Caglar M, Tuncel M, Alpar R. Scintigraphic evaluation of salivary gland dysfunction in patients with thyroid cancer after radioiodine treatment. Clin Nucl Med. 2002;27:767–71.

    Article  PubMed  Google Scholar 

Download references

Conflicts of interest

The authors have no potential conflicts of interest to declare.

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine and Molecular Imaging, School of Medicine, Ajou University, Woncheon-dong, Yeongtong-gu, Suwon, Gyeonggi-do, 443-749, Korea

    Young-Sil An, Joon-Kee Yoon, Su Jin Lee, Hee-Sung Song, Seok-Ho Yoon & Kyung-Sook Jo

Authors
  1. Young-Sil An
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joon-Kee Yoon
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Su Jin Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hee-Sung Song
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Seok-Ho Yoon
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kyung-Sook Jo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Young-Sil An.

Rights and permissions

Reprints and permissions

About this article

Cite this article

An, YS., Yoon, JK., Lee, S.J. et al. Symptomatic late-onset sialadenitis after radioiodine therapy in thyroid cancer. Ann Nucl Med 27, 386–391 (2013). https://doi.org/10.1007/s12149-013-0697-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12149-013-0697-5

Keywords

Search

Navigation